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005: microRNAs and their targets
Nikolaus Rajewsky
Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany
I will summarize our recent efforts to identify as well as quantify
known and novel microRNAs by next-generation sequencing of small
RNA samples. I will further describe proteomics techniques that
allowed us to quantify the impact of miRNAs on protein synthesis of
thousands of human proteins. These data were also used to system-
atically compare existing miRNA target prediction methods. I will
finally present some data highlighting the importance of assaying the
proteome, and not only the transcriptome, in miRNA biology.
006: Identification and molecular characterization
of novel protein partners of piwi in Drosophila
1Manika Pal-Bhadra, 2Utpal Bhadra
1Centre for Chemical Biology, Indian Institute of Chemical
Technology, Hyderabad 500 007, India, 2Functional Genomics and
Gene Silencing Group, Centre for Cellular and Molecular Biology,
Hyderabad 500 007, India
RNA interference is more than a just protective response against
exogenous genetic material. It regulates a variety of phenomena
including gene function, epigenetic regulation, genome control and
stability etc. both in post-transcriptional and transcriptional level. In
Drosophila piwi that encodes a nuclear protein of Argonaute family,
functions as a linker between TGS and PTGS transgene silencing.
PIWI associated small RNA (piRNA) is required for heterochromatin
and telomeric silencing. A wide range of piRNA (nearly 13,000) in fly
genome that are derived from the antisense strand of RNA by the
cleavage of a yet to be identified RNA nuclease, plays central role in
different epigenetic phenomena in the nuclei. But no information has
been documented regarding piRNA and PIWI associated proteins.
Here we isolate and purify Piwi associated transcriptional silencing
complex termed PITS (piwi induced transcriptional Silencing com-
plex) that is required for heterochromatin and transgene silencing.
The PITS complex contains known RNAi factors including Ago-1
and R2D2 and several novel proteins including lamindm0 regulating
nuclear transport, heterochromatin protein 1, Polycomb etc. Piwi is
also directly associated with dre-4, that controls larval development,
sf2 (splicing factor 2) RNA helicase for regulating RNA splicing.
These results demonstrated that PITS complex controls a wide variety
of biochemical phenomena in both cell fractions. Interestingly direct
association of Ago-1 and piwi may provide certain role in cytoplas-
mic RNAi machinery that is corroborated with piwi localization in the
cytoplasm of the somatic cells.
007: Exon evolution and human genomic diversity
Gil Ast
Department of Human Molecular Genetics, Tel Aviv University
Medical School, Tel Aviv, Israel
Alternative splicing enhances transcriptomic diversity and presum-
ably leads to speciation and higher organism complexity, especially in
mammals. Alternative splicing also contributes to human phenotypic
diversity. At least 74% of human genes produce more than one type of
mRNA transcript through alternative splicing; however, it is unclear
which of these products are biologically functional and which are
non-functional products of inaccurate splicing. Thus, understanding
the changes in the genome that dictate fixation of beneficial alterna-
tive splicing events or deleterious events is of great interest. There are
three known origins of alternatively spliced exons: (1) exon shuffling,
which is a form of gene duplication; (2) exonization of intronic
sequences; and (3) change in the mode of splicing from constitutive to
alternative splicing during evolution. I will talk about the evolution of
alternative splicing, and more specifically about the contribution of
the primate-specific retrotransposons called Alu to human genomic
complexity, and how the extensive RNA editing (A-to-I) in the human
transcriptome lead to human-specific transcriptomic diversity.
008: MicroRNAs and non-micro-short RNAs
(nmsRNAs) in cell quiescence and cancer
Anindya Dutta
University of Virginia, Charlottesville, VA 22908, United States
of America
We are using three approaches to discover microRNAs that regulate
cell proliferation. In the first approach, we focused on miRNAs
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induced during differentiation of C2C12 myoblasts into myotubes in
vitro. One of the microRNAs induced during differentiation, miR-206,
suppresses cell proliferation. By surveying mRNAs that are down-
regulated by miR-206 for genes predicted to be targets of the
microRNA, we discovered the mRNA of DNA polymerase alpha p180
is a direct target that is destabilized upon miR-206 transfection. We
now report that additional microRNAs induced during muscle differ-
entiation target other cell-cycle regulators. After noting that targeted
mRNAs are often destabilized by microRNAs, in the second approach,
we tested whether global downregulation of microRNAs by knock-
down of Dicer or Drosha can help identify microRNA-repressed
mRNAs. The principle was proved by the discovery that HMGA2
oncogene is repressed by the growth-suppressive let-7 microRNA.
Indeed, chromosomal translocations in lipomas and leiomyomas de-
repress HMGA2 by deleting the 30UTR that is normally repressed by
let-7. Conversely, downregulation of let-7 has been noted in lung
cancers and large leiomyomas and is correlated with over-expression
of the HMGA2 oncogene. In the third approach we have cloned short
RNAs from androgen-dependent prostate cancer cells grown in the
presence or absence of androgens and subjected them to ultra-high-
throughput sequencing. The frequency of a number of clones present
in the libraries is changed by androgens and we have identified several
microRNAs that change upon androgen depletion. Over 30–40% of the
short RNAs cloned, however, do not correspond to known microRNAs
and are produced by cleavage of known mRNAs and noncoding
RNAs. The diversity and abundance of the non-micro-short RNAs
(nmsRNAs) contrast with how little is known of their function and
suggest that much remains to be done before we understand the bio-
logical functions of many short RNAs present in the cell.
009: Unusual Non-B DNA structure-mediated gene
regulation
Shantanu Chowdhury
Structural Biology and Genome Informatics Unit, Institute of
Genomics and Integrative Biology, Delhi, India
DNA sequence as regulatory elements is well-established; however,
DNA structure is relatively unexplored in this context. Using G-
quadruplex or G4 DNA (structural motifs commonly found within
eukaryote telomeres) as a model we have explored the role of DNA
structure in transcription. Recent findings demonstrating a transcrip-
tion factor that may target DNA structure for gene activation will be
presented. This portends an interesting model that involves cross-talk
between local DNA structure and global chromatin architecture in a
regulatory context.
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